Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of Leukemic Stem Cells in Patients With BCR-ABL-positive Hematopoiesis and Chronic Myeloid Leukemia Patients With BCR-ABL Activity Inhibition Under Tyrosine Kinase Inhibitor Treatment

NCT04104035 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT04104035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04104035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of Leukemic Stem Cells in Patients With BCR-ABL-positive Hematopoiesis and Chronic Myeloid Leukemia Patients With BCR-ABL Activity Inhibition Under Tyrosine Kinase Inhibitor Treatment
Lead sponsor
Ankara University
Phase
Observational
Overall status
Unknown status
Start date
August 13, 2019
Completion date
January 31, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia